Antigen-Based Therapies Using Ignored Determinants of β Cell Antigens Can More Effectively Inhibit Late-Stage Autoimmune Disease in Diabetes-Prone Mice-Reference-Cited by-同舟云学术

Antigen-Based Therapies Using Ignored Determinants of β Cell Antigens Can More Effectively Inhibit Late-Stage Autoimmune Disease in Diabetes-Prone Mice

Published:2005-07-20 Issue:3 Volume:175 Page:1991-1999
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Olcott Angelica P.,Tian Jide,Walker Valerie,Dang Hoa,Middleton Blake,Adorini Luciano,Washburn Lorraine,Kaufman Daniel L.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases

2. Oral tolerance: immune mechanisms and treatment of autoimmune diseases

3. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

4. Cytokine regulation of T-cell function: potential for therapeutic intervention

5. Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases—The Case for Using Ignored Target Cell Antigen Determinants;Cells;2022-03-23

2. Human Amylin: From Pathology to Physiology and Pharmacology;Current Protein & Peptide Science;2019-09-17

3. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice;Journal of Immunology Research;2018

4. Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes;Immunologic Research;2017-10-05

5. Neuroendocrine hormone amylin in diabetes;World Journal of Diabetes;2016